Skip to content

Fluid therapy after cardiac surgery – A feasibility study

A study of cardiac surgical patients to determine if a stroke volume variation guided fluid protocol is superior to standard fluid administration in reducing the total amount of fluid patients receive.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12612000754842
Acronym
FRACAS
Enrollment
144
Registered
2012-07-16
Start date
2013-01-31
Completion date
2013-10-10
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Following cardiac surgery, patients receive large amounts of fluid in the intensive care unit. This may cause problems with wound healing and delay hospital discharge. A planned randomised controlled trial of a restrictive fluid regime as compared to a more liberal approach utilising advance hemodynamic monitoring, aims to reduce the amount of fluid patients receive and reduce hospital length of stay. This feasibility study aims to determine whether this nurse-led protocol is practicable and feasible and will help answer the research question. It will also aim to evaluate how fluid is administered in other cardiac intensive care centres in New Zealand. This study is simple and inexpensive and if it demonstrates a decreased length of hospital stay then this will represent a significant benefit for both individual patients and the health system

Interventions

Stroke volume variation guided fluid administration. Bedside staff will utilise a protocol to guide fluid administration. If the clinician suspects the patient to have a known or suspected inadequate cardiac output (i.e. the cardiac index is < 2.5L/min/m2; poor perfusion;poor urine output) and the stroke voume is >13 then they will be instructed to administer a fluid bolus of 250mls. This will continue until the patient is extubated or they reach 24 hours post-operative.

Sponsors

Dr Shay McGuinness
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
16 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

Adult patients (>16yrs), expected to have cardiac surgery using cardiopulmonary bypass, written infomred consent

Exclusion criteria

Emergency procedure, intra-aortic balloon pump in situ, chronic atrial fibrillation pre-op, atrial fibrillation post-op, open chest post-op, patient likely to die within 24hours

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 17, 2026